申请人:Teng Min
公开号:US06927214B1
公开(公告)日:2005-08-09
Novel non-peptide GLP-1 agonists, pharmaceutical compositions comprising them, use of the non-peptide GLP-1 agonists for the preparation of pharmaceutical compositions and methods for the treatment and/or prevention of disorders and diseases wherein an activation of the human GLP-1 receptor is beneficial, especially metabolic disorders such as IGT, Type 1 diabetes, Type 2 diabetes and obesity.
新型非肽类GLP-1激动剂,包括它们的药物组合物,使用非肽类GLP-1激动剂制备药物组合物以及治疗和/或预防激活人类GLP-1受体有益的疾病和疾病的方法,特别是代谢性疾病,如IGT、1型糖尿病、2型糖尿病和肥胖症。